Hydrogel Microparticles for Digital ELISA Sensitivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current digital ELISA platforms require specialized equipment and techniques, limiting their adoption due to high costs and the need for extensive semiconductor fabrication skills, and they struggle with sensitivity and customization for detecting protein biomarkers at low concentrations.
Innovation Solution
A particle-based assay system using hydrogel microparticles as both solid surfaces and hydrophilic cores to form affinity complexes and template water-in-oil emulsions, allowing for signal generation and accumulation using standard benchtop instruments, enabling wider customization and improved sensitivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If digital ELISA uses specialized microfluidic equipment and semiconductor fabrication techniques, then measurement precision for low-concentration biomarkers is improved, but device complexity and cost increase
Solution Approach 1:
The patent uses disposable hydrogel microparticles that can be easily synthesized and distributed without requiring complex fabrication equipment. These microparticles serve as single-use microreactors, eliminating the need for expensive, specialized microfluidic devices while maintaining digital ELISA functionality for detecting low-concentration biomarkers
Solution Approach 2:
The invention changes the physical state and properties of the reaction environment by using hydrogel microparticles that can absorb and concentrate analytes. This parameter change enables sensitive detection without requiring complex microfluidic control systems, as the hydrogel matrix itself provides the necessary microenvironment for amplification
2Manufacturing precision
If digital ELISA requires extensive semiconductor fabrication skills, then manufacturing precision of microreactors is improved, but ease of manufacture deteriorates
Solution Approach 1:
The patent employs disposable hydrogel microparticles that can be manufactured using simple, scalable methods without requiring semiconductor fabrication facilities. These microparticles are produced through straightforward chemical crosslinking processes that can be performed in standard laboratories, dramatically reducing the skill barrier while maintaining sufficient uniformity for digital ELISA applications
Solution Approach 2:
The hydrogel microparticles self-assemble through spontaneous crosslinking reactions when exposed to appropriate conditions (e.g., pH change, temperature). This self-service mechanism eliminates the need for complex fabrication equipment and highly skilled operators, as the particles automatically form uniform microreactors with the desired properties
3Ease of operation
If conventional ELISA uses well-plate formats, then ease of operation is improved, but measurement precision for low-concentration analytes deteriorates
Solution Approach 1:
The patent segments the conventional well-plate format into millions of individual hydrogel microparticles, each acting as a separate microreactor. This segmentation enables digital ELISA functionality where individual molecule detection becomes possible, dramatically improving measurement precision while maintaining ease of operation through simple particle suspension and incubation procedures
Solution Approach 2:
The hydrogel microparticles serve multiple functions simultaneously: they act as solid surfaces for analyte capture, as microreactors for signal amplification, and as discrete units for digital counting. This multi-functionality achieves high measurement precision without complicating the operational workflow, as all functions are integrated into a single particle system
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system enables efficient capture and quantification of protein biomarkers at low concentrations using standard equipment, enhancing sensitivity and reducing the need for specialized tools, thus democratizing access to digital ELISA technology.
Implementation Method 1
The method selectively immobilizes the analytes of interest onto a chemically modified surface, usually the surface of wells in well plates by specific antigen-antibody binding
Implementation Method 2
determines the quantity of the analytes of interest by measuring signals generated by an enzymatic reporter turning substrate molecules into signaling molecules
Implementation Method 3
partitioning the reaction solution into a large number of picoliter to attoliter microreactors
Data Source
AI summary
A particle-based assay system is disclosed that uses hydrogel microparticles that capture analytes of interest from a sample which are subsequently bound with catalytic reporter complexes. Catalytic reporter complexes bound to the hydrogel microparticles generate signals that are accumulated in the vicinity of the hydrogel microparticle at high concentration (or on or within the hydrogel microparticles). In some circumstances, the reporter complex-bound hydrogel microparticles are encapsulated in an emulsion. Preferably, the emulsion is substantially uniform and contains one hydrogel microparticle per droplet. The accumulated signal generated by the catalytic reporter complexes is contained inside the emulsion, and/or optionally immobilized onto or inside the hydrogel microparticle. Signals are read and analyzed using optical instruments such as flow cytometers. Breaking the emulsion prior to signal analysis is optional. In some embodiments, a sample is introduced to hydrogel microparticles in a dried state to concentrate analytes of interest.